223 related articles for article (PubMed ID: 37313417)
1. T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma.
Xie S; Yan R; Zheng A; Shi M; Tang L; Li X; Liu J; Gan Y; Wang Y; Jiang D; Liu L; Wu H; Wang Z
Front Immunol; 2023; 14():1161417. PubMed ID: 37313417
[TBL] [Abstract][Full Text] [Related]
2. Clonal distribution and intratumour heterogeneity of the B-cell repertoire in oesophageal squamous cell carcinoma.
Zhang C; Huang H; Miao Y; Xiong H; Lu Z
J Pathol; 2018 Nov; 246(3):323-330. PubMed ID: 30027584
[TBL] [Abstract][Full Text] [Related]
3. Immune repertoire: A potential biomarker and therapeutic for hepatocellular carcinoma.
Han Y; Li H; Guan Y; Huang J
Cancer Lett; 2016 Sep; 379(2):206-12. PubMed ID: 26188280
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Clinical Significance of T-Cell Receptor Repertoire in Hepatocellular Carcinoma.
Wang Z; Zhong Y; Zhang Z; Zhou K; Huang Z; Yu H; Liu L; Liu S; Yang H; Zhou J; Fan J; Wu L; Sun Y
Front Immunol; 2022; 13():847263. PubMed ID: 35371059
[TBL] [Abstract][Full Text] [Related]
6. High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC.
Chen Y; Xu Y; Zhao M; Liu Y; Gong M; Xie C; Wu H; Wang Z
Oncoimmunology; 2016; 5(10):e1219010. PubMed ID: 27853640
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy.
Schina A; Sztupinszki Z; Marie Svane I; Szallasi Z; Jönsson G; Donia M
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37604641
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the tumor-infiltrating immune repertoire in muscle invasive bladder cancer.
Benítez R; Yu K; Sirota M; Malats N; Pineda S
Front Immunol; 2023; 14():986598. PubMed ID: 36817478
[TBL] [Abstract][Full Text] [Related]
9. scRNA+TCR+BCR-seq revealed the proportions and gene expression patterns of dual receptor T and B lymphocytes in NPC and NLH.
Yao Y; Wang H; Xu Y; Zhang L; Liu R
Biochem Biophys Res Commun; 2024 May; 709():149820. PubMed ID: 38547605
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
[TBL] [Abstract][Full Text] [Related]
12. Capturing the differences between humoral immunity in the normal and tumor environments from repertoire-seq of B-cell receptors using supervised machine learning.
Konishi H; Komura D; Katoh H; Atsumi S; Koda H; Yamamoto A; Seto Y; Fukayama M; Yamaguchi R; Imoto S; Ishikawa S
BMC Bioinformatics; 2019 May; 20(1):267. PubMed ID: 31138102
[TBL] [Abstract][Full Text] [Related]
13. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of genomic and immunological profiles in Chinese and Western hepatocellular carcinoma populations.
Li W; Wu H; Xu X; Zhang Y
Aging (Albany NY); 2021 Apr; 13(8):11564-11594. PubMed ID: 33867349
[TBL] [Abstract][Full Text] [Related]
15. Antibody Repertoire Analysis of Tumor-Infiltrating B Cells Reveals Distinct Signatures and Distributions Across Tissues.
Aizik L; Dror Y; Taussig D; Barzel A; Carmi Y; Wine Y
Front Immunol; 2021; 12():705381. PubMed ID: 34349765
[TBL] [Abstract][Full Text] [Related]
16. Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts.
Woolaver RA; Wang X; Krinsky AL; Waschke BC; Chen SMY; Popolizio V; Nicklawsky AG; Gao D; Chen Z; Jimeno A; Wang XJ; Wang JH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33414263
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
18. T-cell exhaustion signatures characterize the immune landscape and predict HCC prognosis
Chi H; Zhao S; Yang J; Gao X; Peng G; Zhang J; Xie X; Song G; Xu K; Xia Z; Chen S; Zhao J
Front Immunol; 2023; 14():1137025. PubMed ID: 37006257
[TBL] [Abstract][Full Text] [Related]
19. Diversity and shared T-cell receptor repertoire analysis in esophageal squamous cell carcinoma.
Sudo T; Kawahara A; Ishi K; Mizoguchi A; Nagasu S; Nakagawa M; Fujisaki M; Hino H; Saisho K; Kaku H; Matono S; Mori N; Akiba J; Yamada A; Akagi Y
Oncol Lett; 2021 Aug; 22(2):618. PubMed ID: 34257726
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma.
Zhang Z; Mao M; Wang F; Zhang Y; Shi J; Chang L; Wu X; Zhang Z; Xu P; Lu S
Front Immunol; 2023; 14():1164669. PubMed ID: 37545521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
